Apo Asset Management
Apo Asset Management GmbH is a Düsseldorf-based, privately held fund manager founded in 1999 that manages approximately €3.9 billion in healthcare and multi-asset funds for private and institutional investors across Germany, Austria and Luxembourg, backed by shareholders apoBank and Deutsche Ärzteversicherung.
- Company typePrivate
- Founded1999
- HeadquartersDüsseldorf, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Apo Asset Management does
Apo Asset Management GmbH (apoAsset) is a Düsseldorf-based, privately held fund management company founded in 1999 that specializes in two product verticals: healthcare funds and multi-asset funds. The firm operates 12+ investment products including actively managed equity funds focused on healthcare and biotechnology (apo Medical Opportunities, MEDICAL BioHealth, apo Future Health, apo Medial Balance), multi-asset and fund-of-ETF vehicles (Global ETFs Portfolio, apo Piano, apo Forte, apo Mezzo, apo Vivace Megatrends, DuoPlus, apo Stiftung & Ertrag), and customized investment solutions for institutional clients. Together with co-managed affiliate Medical Strategy GmbH, in which apoAsset holds a minority stake acquired in 2019, the firm manages approximately €3.8–3.9 billion in assets under management as of 2025/2026. Healthcare investment decisions are supported by a Scientific Advisory Board established in 2015.
The firm generates revenue through recurring asset management fees on AUM, with disclosed example pricing of 1.00% p.a. management fees for the R-share class of apo Stiftung & Ertrag and differentiated share classes for retail and institutional investors. apoAsset distributes through three primary channels — direct sales to institutional investors, financial intermediaries (banks, advisors, independent planners) in Germany, Austria and Luxembourg, and online direct distribution via its website with investor profiling. Its shareholder base comprises Deutsche Apotheker- und Ärztebank eG (apoBank) and Deutsche Ärzteversicherung AG, providing captive access to German pharmacist and physician investor networks. The company is regulated by BaFin and is a member of EdW (the German statutory compensation scheme for securities trading firms).
The firm serves three primary customer segments: private investors seeking diversified healthcare and multi-asset exposure, institutional investors (foundations, pension funds, insurance companies, institutional asset managers) requiring professional-grade portfolio solutions, and financial advisors and bank distribution partners across the DACH region. Marketing and education are delivered through multi-channel content including the Börsen-Espresso video series on YouTube, the Kurs & Kompass podcast co-produced with apoBank, monthly investor reports, webinars, LinkedIn corporate presence, and financial media relations with outlets including Handelsblatt, €uro and TiAM Fundresearch. In 2025/2026 the firm received multiple €uro Fund Awards (1st place over 20 years for both apo Medical Opportunities and MEDICAL BioHealth, 1st place over 5 years for Global ETFs Portfolio) and Handelsblatt "Best Managed Fund Offerings 2026" recognition.
Apo Asset Management firmographics
Firmographics- Name
- Apo Asset Management
- Legal name
- Apo Asset Management GmbH
- Website
- https://apoasset.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Apo Asset Management GmbH is a Düsseldorf-based, privately held fund manager founded in 1999 that manages approximately €3.9 billion in healthcare and multi-asset funds for private and institutional investors across Germany, Austria and Luxembourg, backed by shareholders apoBank and Deutsche Ärzteversicherung.
- Ownership category
- akta.pro rank
Where Apo Asset Management is headquartered
LocationHeadquarters
- HQ city
- Düsseldorf
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Apo Asset Management business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Asset Management Fees: apoAsset generates revenue through management fees charged on the funds it manages. The company manages approximately 3.9 billion EUR in assets under management across healthcare and multi-asset funds for private and institutional investors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | apo Stiftung & Ertrag R-share class for private customers |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Apo Asset Management product offering
Product offeringCore offering
Apo Asset Management (apoAsset) is a BaFin-regulated German fund management company that manages approximately 3.9 billion EUR in assets across two core competencies: actively managed healthcare/biotechnology equity funds (co-managed with affiliated Medical Strategy GmbH) and multi-asset fund-of-funds combining ETFs and active strategies. The company distributes its funds to private investors, institutional clients, and financial intermediaries in Germany, Austria, and Luxembourg, and offers customized investment mandates for institutional investors. Revenue is generated primarily through recurring management fees on assets under management.
Product overview
Apo Asset Management GmbH (apoAsset) operates as a specialized fund management company with two core competencies: Healthcare funds and Multi-Asset solutions. The company offers a diversified portfolio of 12+ distinct investment products including equity funds focused on healthcare/biotechnology (apo Medical Opportunities, MEDICAL BioHealth, apo Future Health, apo Medial Balance) and multi-asset funds (Global ETFs Portfolio, apo Piano, apo Forte, apo Mezzo, apo Vivace Megatrends, DuoPlus, apo Stiftung & Ertrag). The firm also provides customized investment solutions for institutional clients. Together with subsidiary Medical Strategy GmbH, apoAsset manages approximately €3.8-3.9 billion in assets under management. The healthcare funds benefit from an interdisciplinary competence network including a scientific advisory board, while multi-asset funds draw from a global network of approximately 400 fund management companies.
Differentiator
Problem solved
Functional benefit
Products and services
- apo Medical Opportunities Actively managed equity fund focusing on global healthcare companies, co-managed by apoAsset and Medical Strategy. Won 1st place over 20 years and 2nd place over 1 year at the €uro Fund Awards 2026 in the Pharmaceuticals & Health category.
- MEDICAL BioHealth Biotechnology-focused equity fund managed by Medical Strategy GmbH. Won 1st place over 20 years and 3rd place over 10 years at the €uro Fund Awards 2026. Article 8 Plus SFDR compliant fund with approximately 1.3 billion EUR in assets.
- apo Future Health (formerly apo Digital Health) Actively managed equity fund with expanded healthcare transformation strategy including medical technologies, diagnostics, monitoring, prevention, digitalization, AI and efficiency. Article 8 SFDR fund available in three share classes.
- Global ETFs Portfolio Multi-asset fund combining selected ETFs from the USA, Europe and Asia. Combines cost-efficient ETFs with active management in a fund wrapper. Won 1st place over 5 years and 3rd place over 3 years at €uro Fund Awards 2026 in the Equity and Bond Funds category. Article 8 SFDR compliant.
- apo Piano Multi-asset fund included in the monthly report subscription service for Multi-Asset funds.
- apo Forte Multi-asset fund included in the monthly report subscription service for Multi-Asset funds.
- apo Mezzo Multi-asset fund included in the monthly report subscription service for Multi-Asset funds.
- apo Vivace Megatrends Multi-asset fund included in the monthly report subscription service for Multi-Asset funds.
- DuoPlus Multi-asset fund included in the monthly report subscription service for Multi-Asset funds.
- apo Stiftung & Ertrag Defensive mixed fund designed for foundations and investors seeking stable growth with regular distributions. Portfolio is broadly diversified with bonds (in Euro) as the core, equities up to 35%, plus target funds, ETFs, commodities and certificates. Targets semi-annual distributions. Formerly known as TopSelect Balance. Manages approximately 140 million EUR with a 4-star Morningstar rating. Article 8 SFDR compliant. 1.00% p.a. management fee on R-share class for private customers.
- apo Medial Balance Healthcare fund included in the monthly report subscription service for healthcare funds.
- Individual Solutions for Institutional Investors Customized investment solutions specifically designed for institutional investors, provided as part of apoAsset's institutional services offerings.
Quantifiable outcome
- apo Medical Opportunities: 1st place over 20 years in Pharma & Gesundheit category at €uro Fund Awards 2026
- +2 more outcomes
Companies that use Apo Asset Management
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Apo Asset Management technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Apo Asset Management partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Medical Strategy GmbHcoreapoAsset holds a stake in Medical Strategy GmbH (since 2019) and they co-manage healthcare funds together. Medical Strategy manages healthcare funds with approximately 1.3 billion EUR in assets and provides biotech investment expertise.
- Wissenschaftlicher Beirat (Scientific Advisory Board)coreScientific advisory board established in 2015, providing healthcare sector expertise including Prof. Dr. Jochen Maas (ex-Sanofi R&D Director). Supports healthcare fund investment decisions with scientific research insights.
Scale indicators6 records
Recent moves9 records
Expansion highlights5 records
Apo Asset Management competitors and assessment
Company assessmentDirect peers
- Deka Investment: DekaBank's asset management arm is one of Germany's largest fund managers with extensive multi-asset, equity and sector fund offerings, directly competing with apoAsset's Publikumsfonds shelf across retail and institutional channels in DACH.
- Union Investment: Major German asset manager with a deep multi-asset and equity fund lineup serving retail and institutional clients; competes head-to-head with apoAsset for German private investor and stiftung/pension fund mandates.
- Flossbach von Storch: German boutique asset manager renowned for its multi-asset flagship (Flossbach von Storch Multiple Opportunities) and global equity strategies; highly comparable in product mix, retail brand profile and DACH distribution model to apoAsset's Global ETFs Portfolio and multi-asset range.
- Bellevue Asset Management: Swiss asset manager specialized in healthcare and biotech strategies (e.g., BB Adamant Healthcare), overlapping directly with apoAsset's Medical Strategy partnership and apo Medical Opportunities healthcare equity franchise.
- HansaInvest: German fund platform (KVG) administering and distributing third-party funds via bank and advisor channels in DACH; a direct competitor for wholesale fund placement and institutional mandates, and a former employer of apoAsset's senior sales lead.
- Bantleon: German asset manager specializing in multi-asset, fixed income and insurance/ALM solutions; comparable in institutional focus and multi-asset capability to apoAsset's multi-asset and individualized institutional solutions.
- ProfitlichSchmidlin: German boutique asset manager running flagship multi-asset strategies for private and institutional investors; closely comparable to apoAsset in boutique positioning, multi-asset focus and DACH client base.
- Bethmann Bank (ABN AMRO): German private bank within ABN AMRO serving wealthy professionals including healthcare specialists; competes with apoAsset for healthcare professional and high-net-worth wealth allocations in Germany.
Broad incumbents
- DWS Group: One of Europe's largest asset managers (Deutsche Bank heritage) with extensive multi-asset, equity and ESG fund offerings; competes with apoAsset at the larger institutional and retail end of the DACH market.
- Allianz Global Investors: Global asset manager within Allianz Group offering multi-asset, equity and sector funds with broad DACH distribution; overlaps with apoAsset in multi-asset retail and institutional pension/insurance segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Apo Asset Management social profiles
Digital presenceApo Asset Management financial estimates
Financial estimateRevenue estimate
Valuation estimate
Apo Asset Management leadership team
Management profileNumber of profiles
Profiles14 records
Apo Asset Management subsidiaries and ownership
Company hierarchySubsidiaries1 record
Apo Asset Management funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Apo Asset Management M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Apo Asset Management
What does Apo Asset Management do?
Apo Asset Management (apoAsset) is a BaFin-regulated German fund management company that manages approximately 3.9 billion EUR in assets across two core competencies: actively managed healthcare/biotechnology equity funds (co-managed with affiliated Medical Strategy GmbH) and multi-asset fund-of-funds combining ETFs and active strategies. The company distributes its funds to private investors, institutional clients, and financial intermediaries in Germany, Austria, and Luxembourg, and offers customized investment mandates for institutional investors. Revenue is generated primarily through recurring management fees on assets under management.
Is Apo Asset Management a public or private company?
Apo Asset Management is a private company. It is classified as corporate owned and is currently operating.
When was Apo Asset Management founded?
Apo Asset Management was founded in 1999. It employs 11 to 50 people.
Where is Apo Asset Management based?
Apo Asset Management is headquartered in Düsseldorf, Germany, in the Europe region.
How does Apo Asset Management make money?
One revenue line is on record: asset Management Fees.
Who are Apo Asset Management's main competitors?
Direct peers on record are Deka Investment, Union Investment, Flossbach von Storch, Bellevue Asset Management, HansaInvest, Bantleon, ProfitlichSchmidlin and Bethmann Bank (ABN AMRO). Broad incumbents are DWS Group and Allianz Global Investors.
Does Apo Asset Management have an API?
No public API is recorded for Apo Asset Management.